ZYDUS LIFESCIENCES
Back to Income Statement
|
ZYDUS LIFESCIENCES Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹19,547 Cr | ₹17,237 Cr | ₹15,110 Cr | ₹14,404 Cr | ₹14,253 Cr |
What is the latest Revenue of ZYDUS LIFESCIENCES ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹19,547 Cr |
| Mar2024 | ₹17,237 Cr |
| Mar2023 | ₹15,110 Cr |
| Mar2022 | ₹14,404 Cr |
| Mar2021 | ₹14,253 Cr |
How is Revenue of ZYDUS LIFESCIENCES Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹19,547 Cr | 13.40 | |
| Mar2024 | ₹17,237 Cr | 14.08 | |
| Mar2023 | ₹15,110 Cr | 4.90 | |
| Mar2022 | ₹14,404 Cr | 1.06 | |
| Mar2021 | ₹14,253 Cr | - | |
Compare Revenue of peers of ZYDUS LIFESCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ZYDUS LIFESCIENCES | ₹113,814.8 Cr | 1.7% | 6% | 12% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,989.0 Cr | 1.7% | 6.4% | 12.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,471.0 Cr | 3% | 2.8% | 0.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹161,290.0 Cr | 2.3% | 9.1% | 44.6% | Stock Analytics | |
| CIPLA | ₹117,820.0 Cr | 0.3% | 6.1% | -3.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,730.0 Cr | -0.1% | 8.9% | 1.9% | Stock Analytics | |
ZYDUS LIFESCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ZYDUS LIFESCIENCES | 1.7% |
6% |
12% |
| SENSEX | 0.9% |
4.2% |
-6% |
You may also like the below Video Courses